The use of genetically humanized animal models for personalized medicine approaches

For many genetic diseases, researchers are developing personalized medicine approaches. These sometimes employ custom genetic interventions such as antisense-mediated exon skipping or genome editing, aiming to restore protein function in a mutation-specific manner. Animal models can facilitate the d...

Full description

Bibliographic Details
Main Authors: Annemieke Aartsma-Rus, Maaike van Putten, James Dowling
Format: Article
Language:English
Published: The Company of Biologists 2020-02-01
Series:Disease Models & Mechanisms
Subjects:
Online Access:http://dmm.biologists.org/content/13/2/dmm041673
id doaj-9a55427efd994412af34cf2720b2636b
record_format Article
spelling doaj-9a55427efd994412af34cf2720b2636b2020-11-24T22:10:28ZengThe Company of BiologistsDisease Models & Mechanisms1754-84031754-84112020-02-0113210.1242/dmm.041673041673The use of genetically humanized animal models for personalized medicine approachesAnnemieke Aartsma-Rus0Maaike van Putten1Annemieke Aartsma-Rus2James Dowling3Maaike van Putten4 Department of Human Genetics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands Department of Human Genetics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands Department of Human Genetics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands Department of Human Genetics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands Department of Human Genetics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands For many genetic diseases, researchers are developing personalized medicine approaches. These sometimes employ custom genetic interventions such as antisense-mediated exon skipping or genome editing, aiming to restore protein function in a mutation-specific manner. Animal models can facilitate the development of personalized medicine approaches; however, given that they target human mutations and therefore human genetic sequences, scientists rely on the availability of humanized animal models. Here, we outline the usefulness, caveats and potential of such models, using the example of the hDMDdel52/mdx model, a humanized model recently generated for Duchenne muscular dystrophy (DMD).http://dmm.biologists.org/content/13/2/dmm041673genetic therapiesgenome editingexon skippingpre-clinical studiesmuscular dystrophy
collection DOAJ
language English
format Article
sources DOAJ
author Annemieke Aartsma-Rus
Maaike van Putten
Annemieke Aartsma-Rus
James Dowling
Maaike van Putten
spellingShingle Annemieke Aartsma-Rus
Maaike van Putten
Annemieke Aartsma-Rus
James Dowling
Maaike van Putten
The use of genetically humanized animal models for personalized medicine approaches
Disease Models & Mechanisms
genetic therapies
genome editing
exon skipping
pre-clinical studies
muscular dystrophy
author_facet Annemieke Aartsma-Rus
Maaike van Putten
Annemieke Aartsma-Rus
James Dowling
Maaike van Putten
author_sort Annemieke Aartsma-Rus
title The use of genetically humanized animal models for personalized medicine approaches
title_short The use of genetically humanized animal models for personalized medicine approaches
title_full The use of genetically humanized animal models for personalized medicine approaches
title_fullStr The use of genetically humanized animal models for personalized medicine approaches
title_full_unstemmed The use of genetically humanized animal models for personalized medicine approaches
title_sort use of genetically humanized animal models for personalized medicine approaches
publisher The Company of Biologists
series Disease Models & Mechanisms
issn 1754-8403
1754-8411
publishDate 2020-02-01
description For many genetic diseases, researchers are developing personalized medicine approaches. These sometimes employ custom genetic interventions such as antisense-mediated exon skipping or genome editing, aiming to restore protein function in a mutation-specific manner. Animal models can facilitate the development of personalized medicine approaches; however, given that they target human mutations and therefore human genetic sequences, scientists rely on the availability of humanized animal models. Here, we outline the usefulness, caveats and potential of such models, using the example of the hDMDdel52/mdx model, a humanized model recently generated for Duchenne muscular dystrophy (DMD).
topic genetic therapies
genome editing
exon skipping
pre-clinical studies
muscular dystrophy
url http://dmm.biologists.org/content/13/2/dmm041673
work_keys_str_mv AT annemiekeaartsmarus theuseofgeneticallyhumanizedanimalmodelsforpersonalizedmedicineapproaches
AT maaikevanputten theuseofgeneticallyhumanizedanimalmodelsforpersonalizedmedicineapproaches
AT annemiekeaartsmarus theuseofgeneticallyhumanizedanimalmodelsforpersonalizedmedicineapproaches
AT jamesdowling theuseofgeneticallyhumanizedanimalmodelsforpersonalizedmedicineapproaches
AT maaikevanputten theuseofgeneticallyhumanizedanimalmodelsforpersonalizedmedicineapproaches
AT annemiekeaartsmarus useofgeneticallyhumanizedanimalmodelsforpersonalizedmedicineapproaches
AT maaikevanputten useofgeneticallyhumanizedanimalmodelsforpersonalizedmedicineapproaches
AT annemiekeaartsmarus useofgeneticallyhumanizedanimalmodelsforpersonalizedmedicineapproaches
AT jamesdowling useofgeneticallyhumanizedanimalmodelsforpersonalizedmedicineapproaches
AT maaikevanputten useofgeneticallyhumanizedanimalmodelsforpersonalizedmedicineapproaches
_version_ 1725807907507798016